Citations 2

P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS

HemaSphere | August 22, 2023 | Volume: 7 | Issue: S3 | Pages: e47546cf

10.1097/01.hs9.0000969432.47546.cf

Comparison of Treatment-Emergent Adverse Events of Covalent BTK Inhibitors in Clinical Trials in B-Cell Malignancies: A Systematic Review and Meta-Analysis

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9882-9884

10.1182/blood-2022-168152